We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety/Efficacy of Systane Free vs Refresh Tears

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00348322
First Posted: July 4, 2006
Last Update Posted: September 25, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Alcon Research
  Purpose
The objective of this study is to evaluate the safety and efficacy of Systane Free FID 105783 in comparison to Refresh Tears Lubricant Eye Drops (Allergan) in a specified population of dry eye patients.

Condition Intervention
Dry Eye Drug: Systane Free Lubricant Eye Drops

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: An Evaluation of the Safety and Efficacy of Systane Free FID 105783 - II

Resource links provided by NLM:


Further study details as provided by Alcon Research:

Primary Outcome Measures:
  • Corneal Staining change from baseline

Secondary Outcome Measures:
  • Comfort, Conjunctival Staining

Estimated Enrollment: 100
Study Start Date: July 2006
Study Completion Date: November 2006
Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • > = 3 stain using NEI grid and need artificial tears at least some of the time.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00348322


Locations
United States, Texas
El Paso Facility
El Paso, Texas, United States, 79904
Sponsors and Collaborators
Alcon Research
Investigators
Study Director: Mike Christensen Alcon Research
  More Information

ClinicalTrials.gov Identifier: NCT00348322     History of Changes
Other Study ID Numbers: C-06-22
First Submitted: June 30, 2006
First Posted: July 4, 2006
Last Update Posted: September 25, 2008
Last Verified: September 2008

Additional relevant MeSH terms:
Lubricant Eye Drops
Ophthalmic Solutions
Pharmaceutical Solutions